An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.
Some professionals said the popularity for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Material Elimination
According to TikTok, the service has taken down violative content and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the platform safe and investing in strengthening compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.
Within minutes of entering one community, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Pricing
Inside these groups, posts display dark colored parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.
